RecruitingNot ApplicableNCT07687290

Comparative Study Between Pericapsular Nerve Group Block (PENG) And Pericapsular Nerve Group (PENG) Block Combined With Lateral Femoral Cutaneous Nerve (LFCN) Block for Positioning Analgesia Prior to Spinal Anesthesia in Hip Fracture Patients


Sponsor

Ain Shams University

Enrollment

24 participants

Start Date

Jun 18, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

To evaluate and compare the effectiveness of the Pericapsular Nerve Group (PENG) block alone versus the PENG block combined with the Lateral Femoral Cutaneous Nerve (LFCN) block in providing adequate analgesia for patient positioning during spinal anesthesia in individuals undergoing surgery for hip fracture.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria5

  • Age 18-70 years.
  • ASA I-II.
  • Confirmed primary unilateral hip fracture.
  • Scheduled for surgery under spinal anesthesia.
  • Patients able to provide informed consent.

Exclusion Criteria6

  • Allergy to local anesthetics.
  • Coagulopathy or on anticoagulant therapy.
  • Infection at injection site.
  • Pre-existing neurological deficits in the lower limbs.
  • Multiple trauma or polytrauma (If other injuries might interfere with positioning or pain scoring).
  • Previous surgery on the ipsilateral hip affecting anatomy or nerve distribution.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPENG Block

Pericapsular Nerve Group Block

PROCEDURELCFN block

Lateral Femoral Cutaneous Nerve block

DRUGbupivacaine 0.25%.

0.25% of Bupivacaine (Bupivacaine 0.5% is added to Lidocaine 2% in the same volume)

DRUGXylocaine 2 %

local infilteration at the insertion site


Locations(1)

Ain Shams University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07687290


Related Trials